New insights in the differential diagnosis of bladder pain syndrome;Neue erkenntnisse zur differenzialdiagnostik des bladder-pain-syndroms

Aktuelle Urologie

Volumn 41, Issue 2, 2010, Pages 107-118

  Schwalenberg, T ^a   Neuhaus, J ^a   Horn, L C ^b   Alexander, H ^a   Zimmermann, G ^a   Ho Thi, P ^a   Mallock, T ^a   Stolzenburg, J U ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Beta hCG; Idiopathic urgency; Interstitial cystitis; Receptor expression; Urothelial pathology

Indexed keywords

EID: 77949893555     PISSN: 00017868     EISSN: 14388820     Source Type: Journal    
DOI: 10.1055/s-0030-1247272     Document Type: Article

References (52)

1. van de Merwe J P., Nordling J, Bouchelouche P et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 2008 53 60-67
2. Fall M, Baranowski A P., Elneil S et al. EAU Guidelines on chronic pelvic pain. Eur Urol 2009 [Epub ahead of print]
3. Binder I, van Ophoven A. [The complexity of chronic pelvic pain exemplified by the condition currently called interstitial cystitis. Part1: Background and basic principles]. Aktuelle Urol 2008 39 205-214
4. Hanno P M., Landis J R., Matthews-Cook Y et al. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol 1999 161 553-557
5. Gillenwater J Y., Wein A J. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August2829, 1987. J Urol 1988 140 203-206
6. Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002 21 167-178
7. Rosamilia A, Igawa Y, Higashi S. Pathology of interstitial cystitis. Int J Urol 2003 10 Suppl 11-15
8. Kelada E, Jones A. Interstitial cystitis. Arch Gynecol Obstet 2007 275 223-229
9. Messing E M., Stamey T A. Interstitial cystitis: early diagnosis, pathology, and treatment. Urology 1978 12 381-392
10. Johansson S L., Fall M. Clinical features and spectrum of light microscopic changes in interstitial cystitis. J Urol 1990 143 1118-1124
11. Gillespie L, Said J, Sostrin S et al. Immunofluorescent and histochemical staining confirm the identification of the many diseases called interstitial cystitis. Br J Urol 1990 66 265-273
12. Lynes W L., Flynn S D., Shortliffe L D. et al. Mast cell involvement in interstitial cystitis. J Urol 1987 138 746-752
13. Shear S, Mayer R. Development of glomerulations in younger women with interstitial cystitis. Urology 2006 68 253-256
14. Tomaszewski J E., Landis J R., Russack V et al. Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study. Urology 2001 57 67-81
15. Smith B H., Dehner L P. Chronic ulcerating interstitial cystitis (Hunners ulcer). A study of 28cases. Arch Pathol 1972 93 76-81
16. Irwin P, Galloway N T. Impaired bladder perfusion in interstitial cysitis: a study of blood supply using laser Doppler flowmetry. J Urol 1993 149 890-892
17. Pontari M A., Hanno P M., Ruggieri M R. Comparison of bladder blood flow in patients with and without interstitial cystitis. J Urol 1999 162 330-334
18. Larsen S, Thompson S A., Hald T et al. Mast cells in interstitial cystitis. Br J Urol 1982 54 283-286
19. Theoharides T C., Sant G R. The mast cell as a neuro-immunendocrine ffector in interstitial cystitis. In: Sant G, editor. Interstitial cystitis. Philadelphia: Lippincott-Raven; 1997: 101108
20. Kastrup J, Hald T, Larsen S et al. Histamine content and mast cell count of detrusor muscle in patients with interstitial cystitis and other types of chronic cystitis. Br J Urol 1983 55 495-500
21. Peeker R, Aldenborg F, Dahlstrom A et al. Increased tyrosine hydroxylase immunoreactivity in bladder tissue from patients with classic and nonulcer interstitial cystitis. J Urol 2000 163 1112-1115
22. Keay S, Zhang C O., Chai T et al. Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor in men with interstitial cystitis versus chronic pelvic pain syndrome. Urology 2004 63 22-26
23. Meyers K E., Pfieffer S, Lu T et al. Genitourinary complications of systemic lupus erythematosus. Pediatr Nephrol 2000 14 416-421
24. Linardou H, Dahabreh I J., Kanaloupiti D et al. Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer. Lancet Oncol 2008 9 962-972
25. Greenbaum D, Colangelo C, Williams K et al. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 2003 4 117-117
26. Hohlbrugger G. Urinary potassium and the overactive bladder. BJU Int 1999 83 Suppl 2 22-28
27. Parsons C L. The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology 2007 69 9-16
28. Slobodov G, Feloney M, Gran C et al. Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. J Urol 2004 171 1554-1558
29. Lavelle J P., Meyers S A., Ruiz W G. et al. Urothelial pathophysiological changes in feline interstitial cystitis: a human model. Am J Physiol Renal Physiol 2000 278 F540-F553
30. Zimmermann G, Ackermann W, Alexander H. Epithelial human chorionic gonadotropin is expressed and produced in human secretory endometrium during the normal menstrual cycle. Biol Reprod 2009 80 1053-1065
31. Alexander H, Biesold C, Weber W et al. [Immunohistochemical evidence of immuno-reactive hCG in the secretory endometrium in women]. Zentralbl Gynakol 1997 119 Suppl1 17-22
32. Neuhaus J, Scholler U, Freick K et al. [Myofibroblasts and afferent signalling in the urinary bladder: A concept]. Urologe A 2008 47 1085-1090
33. Roosen A, Datta S N., Chowdhury R A. et al. Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurooxin typea treatment. Eur Urol 2009 55 1440-1448
34. Mukerji G, Yiangou Y, Grogono J et al. Localization of M2 and M3 muscarinic receptors in human bladder disorders and their clinical correlations. J Urol 2006 176 367-373
35. Faussone-Pellegrini M S. Histogenesis, structure and relationships of interstitial cells of Cajal (ICC): from morphology to functional interpretation. Eur J Morphol 1992 30 137-148
36. Mansfield K J., Liu L, Moore K H. et al. Molecular characterization of M2 and M3 muscarinic receptor expression in bladder from women with refractory idiopathic detrusor overactivity. BJU Int 2007 99 1433-1438
37. Hinata N, Shirakawa T, Okada H et al. Quantitative analysis of the levels of expression of muscarinic receptor subtype RNA in the detrusor muscle of patients with overactive bladder. Mol Diagn 2004 8 17-22
38. Pontari M A., Braverman A S., Ruggieri M RS. The M2 muscarinic receptor mediates in vitro bladder contractions from patients with neurogenic bladder dysfunction. Am J Physiol Regul Integr Comp Physiol 2004 286 R874-R880
39. Stevens L A., Chapple C R., Chess-Williams R. Human idiopathic and neurogenic overactive bladders and the role of M2 muscarinic receptors in contraction. Eur Urol 2007 52 531-538
40. Mansfield K J., Liu L, Mitchelson F J. et al. Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing. Br J Pharmacol 2005 144 1089-1099
41. Hampel C, Gillitzer R, Pahernik S et al. [Changes in the receptor profile of the aging bladder]. Urologe A 2004 43 535-541
42. OReilly B A., Kosaka A H., Knight G F. et al. P2X receptors and their role in female idiopathic detrusor instability. J Urol 2002 167 157-164
43. Apostolidis A, Dasgupta P, Fowler C J. Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 2006 49 644-650
44. Rudick C N., Bryce P J., Guichelaar L A. et al. Mast cell-derived histamine mediates cystitis pain. PLoS ONE 2008 3 e2096-e2096
45. Bouchelouche K, Bouchelouche P. Cysteinyl leukotriene d(4) increases human detrusor muscle responsiveness to histamine. J Urol 2006 176 361-366
46. Neuhaus J, Weimann A, Stolzenburg J U. et al. Histamine receptors in uman detrusor smooth muscle cells: physiological properties and immunohistochemical representation of subtypes. World J Urol 2006 24 202-209
47. Dasgupta P, Sharma S D., Womack C et al. Cimetidine in painful bladder syndrome: a histopathological study. BJU Int 2001 88 183-186
48. Theoharides T C., Sant G R. Hydroxyzine therapy for interstitial cystitis. Urology 1997 49 108-110
49. Parsons J K., Parsons C L. The historical origins of interstitial cystitis. JUrol 2004 171 20-22
50. Ueda T, Sant G R., Hanno P M. et al. Interstitial cystitis and frequency-urgency syndrome (OAB syndrome). Int J Urol 2003 10 Suppl 39-48
51. Hanno P, Keay S, Moldwin R et al. International Consultation on IC Rome, September 2004/Forging an International Consensus: progress in painful bladder syndrome/interstitial cystitis. Report and abstracts, Int Urogynecol J Pelvic Floor Dysfunct 2005 16 Suppl1 2-34
52. Hanno P, Baranowski A P., Fall M et al. Painful bladder syndrome (including interstitial cystitis). In: AbramsP, WeinA, CardozoL, editors. Incontinence. Paris: Health Publication Limited; 2005: 14651520